PCSK9 and pancreatic serous cystadenoma: Serum PCSK9 levels were measured in 100 patients with autoimmune liver diseases — 57 with primary sclerosing cholangitis (PSC), 33 with primary biliary cholangitis (PBC), and 10 with autoimmune hepatitis (AIH)—and 88 healthy controls.